Saturday, September 6, 2008 - 6:52PM EST

Review Articles

1. Novel immune-based treatment strategies for chronic lymphocytic leukemia.

Author
Wierda WG; Kipps TJ; Keating MJ;
Institution
The University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. wwierda@mdanderson.org
Journal
J Clin Oncol. 2005 Sep 10;23(26):6325-32.
Abstract URL
Click here to view abstract

2. Chronic lymphocytic leukemia: economic burden and quality of life: literature review.

Author
Stephens JM; Gramegna P; Laskin B; Botteman MF; Pashos CL;
Institution
HERQuLES, Bethesda, Maryland, USA.
Journal
Am J Ther. 2005 Sep-Oct;12(5):460-6.
Abstract URL
Click here to view abstract

3. Monoclonal antibody therapy of chronic lymphocytic leukemia.

Author
Cheson BD;
Institution
Lombardi Comprehensive Cancer Center, Georgetown University Hospital, 3800 Reservoir Rd, NW, Washington, DC, USA. bdc4@georgetown.edu
Journal
Cancer Immunol Immunother. 2006 Feb;55(2):188-96. Epub 2005 Sep 27.
Abstract URL
Click here to view abstract

4. Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?

Author
Bruserud O; Tronstad KJ; McCormack E; Gjertsen BT;
Institution
Section for Hematology, Institute of Medicine, The University of Bergen, Bergen, Norway. oystein.bruserud@haukeland.no
Journal
Cancer Immunol Immunother. 2006 Feb;55(2):221-8. Epub 2005 Jul 21.
Abstract URL
Click here to view abstract

5. Immunotherapy in chronic lymphocytic leukemia.

Author
Bruserud O; McCormack E; Gjertsen BT;
Institution
Section for Hematology, Institute of Medicine, The University of Bergen, Bergen, Norway. oystein.bruserud@haukeland.no
Journal
Cancer Immunol Immunother. 2006 Feb;55(2):185-7. Epub 2005 Jul 7.

6. The evolving role of lenalidomide in the treatment of hematologic malignancies.

Author
Kastritis E; Dimopoulos MA; Kastritis E; Dimopoulos MA;
Institution
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, School of Medicine, Athens, Greece.
Journal
Expert Opin Pharmacother. 2007 Mar;8(4):497-509.
Abstract URL
Click here to view abstract

7. Dendritic cell vaccines for leukemia patients.

Author
Schmitt A; Hus I; Schmitt M; Schmitt A; Hus I; Schmitt M;
Institution
Tumor Immunology Group, University of Ulm, Clinic for Internal Medicine III, Robert-Koch-Str. 8, 89081 Ulm, Germany. anita.schmitt@uni-ulm.de
Journal
Expert Rev Anticancer Ther. 2007 Mar;7(3):275-83.
Abstract URL
Click here to view abstract

8. Flavopiridol in the treatment of chronic lymphocytic leukemia.

Author
Christian BA; Grever MR; Byrd JC; Lin TS;
Institution
Division of Hematology and Oncology, Ohio State University, Columbus, Ohio 43210, USA.
Journal
Curr Opin Oncol. 2007 Nov;19(6):573-8.
Abstract URL
Click here to view abstract

9. Recent progress in the management of chronic lymphocytic leukemia.

Author
Robak T;
Institution
Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland. robaktad@csk.umed.lodz.pl
Journal
Cancer Treat Rev. 2007 Dec;33(8):710-28. Epub 2007 Sep 27.
Abstract URL
Click here to view abstract

10. Cellular immune therapy for chronic lymphocytic leukemia.

Author
Kater AP; van Oers MH; Kipps TJ;
Institution
Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl
Journal
Blood. 2007 Oct 15;110(8):2811-8. Epub 2007 Jul 16.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4